🇺🇸 dexamethsone in United States

48 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fatigue — 9 reports (18.75%)
  2. Deep Vein Thrombosis — 5 reports (10.42%)
  3. Dyspnoea — 5 reports (10.42%)
  4. Vomiting — 5 reports (10.42%)
  5. Abdominal Pain — 4 reports (8.33%)
  6. Constipation — 4 reports (8.33%)
  7. Cough — 4 reports (8.33%)
  8. Death — 4 reports (8.33%)
  9. Nausea — 4 reports (8.33%)
  10. Plasma Cell Myeloma — 4 reports (8.33%)

Source database →

Other Other approved in United States

Frequently asked questions

Is dexamethsone approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for dexamethsone in United States?

University of Chicago is the originator. The local marketing authorisation holder may differ — check the official source linked above.